EXETER, N.H., April 21, 2026 /PRNewswire/ — Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient Circuit (APC™) which now includes therapy settings for neonatal and infant patients. The cleared APC enables the HVT 2.0 high velocity therapy system to deliver therapy across a 2–45 L/min flow range using a single disposable patient circuit.

BVI Medical announced today that it received CE mark for its Virtuoso next-generation phaco-vitrectomy surgical platform.

Conavi Medical announced today that it received FDA 510(k) clearance for its next-generation hybrid imaging system.